MFA WEALTH ADVISORS, LLC

MFA Wealth Advisors' $586.7 million Q2 2026 book grew 15.4% from $508.2 million, but two of its largest cuts point to a real repositioning rather than simple growth. The iShares S&P 500 Value ETF (IUSV) was slashed 90%, from $16.3 million (3.2% of assets) to $1.8 million (0.3%), while iShares Gold Trust (IAU) was cut 82%, from $11.4 million to $1.7 million. Neither cut reads as an abandonment of the underlying theme: a new $16.6 million stake in Avantis U.S. Large Cap Value (AVLV) landed immediately as a top-10 position, effectively swapping a passive value index for a more systematic value-factor product from a different provider, while ProShares Bitcoin Strategy (BITO) grew 62.6% in shares to $4.1 million — gold exposure down, Bitcoin-futures exposure up. Elsewhere, the manager exited Health Care Select Sector SPDR (XLV, -$10.9 million) and Exxon Mobil (XOM, -$7.4 million) entirely, along with Lockheed Martin (LMT) and Copart (CPRT), while opening a new $14.6 million position in SPDR S&P Biotech (XBI) — a swap of broad health care sector exposure for the more volatile biotech sub-sector. RTX Corporation (RTX) and Micron (MU) were also added as fresh positions, and Meta Platforms (META) entered the book at $6.3 million.